Junfei Zhao

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responses

  Nature Communications · 2026-06-25

• Genetic Analysis of Acral Melanomas From Southern African Patients

  Pigment Cell & Melanoma Research · 2026-06-14

• Supplementary Data F1 from Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence

  2025-12-17

• Supplementary Data T1 from Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence

  2025-12-17

• Supplemental Figure 3 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

  2025-11-24

• Supplemental Figure 7 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

  2025-11-24

• Supplemental Tables from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

  2025-11-24

• Supplemental Figure 1 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

  2025-11-24

• Supplemental Figure 2 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

  2025-11-24

• Supplemental Figure 4 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

  2025-11-24

• Supplemental Figure 5 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

  2025-11-24

• Supplemental Figure 6 from <i>NFE2L2</i> Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

  2025-11-24

• Pre-malignant extracellular matrix drives leukemia transformation through reprogramming of pre-leukemic stem cells

  Blood · 2025-11-03

• Measurable Residual Disease (MRD) Dynamics Reveals a Therapeutic Vulnerability State for Early Immunotherapy Interception in Multiple Myeloma (MM)

  Clinical Lymphoma Myeloma & Leukemia · 2025-09-01

• Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

  UNC Libraries · 2025-07-18

• Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

  UNC Libraries · 2025-07-18

• A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies

  Cancer Cell · 2025-03-29 · 4 citations

• Supplementary Table 1 from TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas

  2024-11-04

• Supplementary Data from TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human GliomasPreprint

  2024-11-04

• Data from TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human GliomasPreprint

  2024-11-04